Albany Molecular Research, Inc. renames two key acquisitions
18-Jan-2001 -
Albany Molecular Research, Inc. (NASDAQ:AMRI) today announced it has
renamed two key acquisitions. Both acquisitions will no longer use their former names and will
henceforth become known as Albany Molecular Research.
EnzyMed, located in Iowa City, IA, has been renamed "Albany Molecular ...
active pharmaceutical ingredients
biocatalysis
biotechnology
+6